Busulfan and Pulmonary mass - a phase IV clinical study of FDA data

Summary:

Pulmonary mass is reported as a side effect among people who take Busulfan (busulfan), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Piperacillin And Tazobactam, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Pulmonary mass when taking Busulfan. It is created by eHealthMe based on reports of 14,527 people who have side effects when taking Busulfan from the FDA, and is updated regularly.

What is Busulfan?

Busulfan has active ingredients of busulfan. eHealthMe is studying from 14,527 Busulfan users. Check the latest studies of Busulfan.

What is Pulmonary mass?

Pulmonary mass is found to be associated with 1,139 drugs and 920 conditions by eHealthMe. Check the latest studies of Pulmonary mass.

On Jul, 13, 2026

14,527 people reported to have side effects when taking Busulfan.
Among them, 14 people (0.1%) have Pulmonary mass.

Among these 14 people:

How long have people been on Busulfan when they have Pulmonary mass? *

What is the gender of people who have Pulmonary mass when taking Busulfan? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Pulmonary mass when taking Busulfan? *

What are other drugs people take besides Busulfan? *

Piperacillin And Tazobactam: 6 people, 42.86%
Cyclophosphamide: 3 people, 21.43%
Ciclosporin: 2 people, 14.29%
Zovirax: 1 person, 7.14%
Magnesium Oxide: 1 person, 7.14%
Amaryl: 1 person, 7.14%
Amlodipine: 1 person, 7.14%
Azacitidine: 1 person, 7.14%
Bactrim: 1 person, 7.14%
Breo Ellipta: 1 person, 7.14%

What are other side effects people have besides Pulmonary mass? *

Cough: 9 people, 64.29%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 9 people, 64.29%
Thrombocytopenia (decrease of platelets in blood): 9 people, 64.29%
Dyspnea (difficult or laboured breathing): 9 people, 64.29%
Pleural Effusion (water on the lungs): 9 people, 64.29%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 57.14%
Respiratory Tract Infection Fungal: 8 people, 57.14%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 8 people, 57.14%
Chest Pain: 8 people, 57.14%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 3 people, 21.43%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 10 people, 71.43%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 8 people, 57.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 14.29%
Type 2 Diabetes: 1 person, 7.14%
Immunodeficiency Disorders: 1 person, 7.14%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 7.14%
Epstein-Barr Virus Infection: 1 person, 7.14%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Busulfan and have Pulmonary mass?

- Check whether Pulmonary mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Busulfan:

Busulfan (14,527 reports)

Pulmonary mass treatments and more:

Pulmonary mass (17,472 reports)

Browse all side effects of Busulfan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary mass:

Pulmonary mass (1,139 drugs)

Browse all the conditions that are associated with Pulmonary mass:

Pulmonary mass (920 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on busulfan (the active ingredients of Busulfan) and Busulfan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.